| Pharmaceutical active ingredients: |
| Methylprednisolone |
| Available forms, composition and doses of Meprdl: |
| N / A |
| Meprdl medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsOestrogens and progesterones and related synthetic drugsTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AA01 - MethylprednisoloneD10AA02 - MethylprednisoloneH02AB04 - Methylprednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mepidon | Normethadone | Unidentified Pharmaceutical Company |
| Mepiosine | Meprobamate | Unidentified Pharmaceutical Company |
| Mepirodipine | Barnidipine | Unidentified Pharmaceutical Company |
| Meposed | Meprobamate | Unidentified Pharmaceutical Company |
| Mepranil | Meprobamate | Unidentified Pharmaceutical Company |
| Meprin | Meprobamate | Unidentified Pharmaceutical Company |
| Meprindon | Meprobamate | Unidentified Pharmaceutical Company |
| Mepro-Analgesic | Meprobamate | Unidentified Pharmaceutical Company |
| Meprobam | Meprobamate | Unidentified Pharmaceutical Company |
| Meproban | Meprobamate | Unidentified Pharmaceutical Company |